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T
he dying light of the George W. 
Bush presidency was marked 
by, among other things, a 
legislative move to derail recent gains 
in the federal government’s opening 
of science. In particular, the innocuous 
sounding “Fair Copyright in Research 
Works Act” (HR 6845) introduced 
into the House by John Conyers, Jr. 
(DEM-MI), on 9 September 2008 [1] 
was poised to shut down the National 
Institutes of Health (NIH) Public 
Access Policy [2], as well as forestall 
the spread of this open-access spirit 
to other areas of federally sponsored 
research and scholarship. Hearings 
were held, but the bill did not make it 
through the House. End of story? Not 
quite.
Certainly, the Obama presidency 
promises, among so many things, 
an improved regard for science. Yet 
I can’t help but agree with Peter 
Suber’s prediction that Congress will 
see the likes of the Fair Copyright in 
Research Works Act again, though 
perhaps not from Conyers, who was 
an early supporter of Obama [3]. The 
back story on this bill is complicated 
by the publishers executing an about-
face on “archiving rights,” which they 
have traditionally supported, but it 
speaks to a larger battle underway that 
has everything to do with the public 
standing of research and scholarly 
work.
Conyers’ bill, with strong backing 
from both the profit and nonprofit 
scholarly publishing organizations, 
would preclude federal agencies 
from retaining any claim on research 
articles in which the work had been 
government funded, specifically 
targeting any right that “involves the 
availability to the public of that work” 
[1]. What is held to be “unfair” in the 
bill is government interference with 
the publisher’s exclusive ownership 
over research. This is not, however, 
a case of keeping the government’s 
clumsy hand off a free market. The 
scholarly publishing market depends 
on government interference in the 
first instance. The government allows 
publishers to exercise monopoly rights 
over this research through copyright 
law, a form of market interference 
warranted by the works’ contribution 
to “the progress of Science and useful 
Arts,” as the United States Constitution 
puts it [4]. And if that were not 
enough, the government also funds 
directly and indirectly the production, 
authoring, and reviewing of the 
content.
What the NIH’s Public Access 
Policy—which had been supported by 
no less than 33 Nobel Prize laureates, 
the Taxpayers Alliance for Access, 
and leading research libraries—had 
established was a public exception 
to that monopoly. It was a trade-off 
that protected the initial intent of 
the constitutional sense of copyright, 
as greater access contributes to the 
progress of science and such useful arts 
as medicine. 
What is strangely amiss in the 
publishers’ support for outlawing the 
NIH Public Access Policy is that they 
support the upshot of this initiative 
with their own current copyright 
policies. While a growing number 
of open-access journals provide 
immediate access to the published 
version, even subscription-based 
publishers had originally been happy 
enough to grant authors the right to 
do what they were already doing, which 
was putting PDFs of their articles up 
on their websites. Still, it was not long 
before the publishers began to limit 
authors’ archiving rights, imposing 
an embargo period of perhaps a year 
following publication after which the 
author is permitted to archive the 
final peer-reviewed draft (rather than 
the published version) [5]. Now, as 
indicated by their support for the 
Fair Copyright in Research Works 
Act, publishers are taking a stand 
against archiving. As the International 
Association of STM Publishers recently 
put it, “publishers do not believe that 
self-archiving offers a sustainable 
alternative for scientific publishing” 
[6].
 One reason for the publishers’ 
change of heart is that archiving is 
catching on, amid growing public 
expectations that research is a public 
good that should be made freely 
available online. Research libraries 
are setting up dedicated archives for 
just such purposes. Funding agencies, 
foundations, and institutions are 
putting in place policies supporting 
archiving as a duty and point of pride. 
Still, when the NIH established its 
Public Access Policy in April of 2008, 
the terms carefully reflected the 
publisher’s own archiving policies. 
Authors were asked to deposit the 
“final peer-reviewed manuscript” in 
PubMed Central on publication, which 
would then be made public no later 
than 12 months after publication [2]. 
In this way, the subscription-based 
publishers had forestalled open access 
in any strict sense, by ensuring that the 
public and health professionals had 
decidedly second-class access to this 
work.
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Yet that wasn’t enough to allay the 
concerns of the publisher associations. 
Having won archiving restrictions, 
which were designed to protect the 
value of journal subscriptions—both 
for immediacy and accuracy of access—
they have decided that archiving 
policies are a threat in principle. In 
testifying last September in support of 
the bill before the Subcommittee on 
Courts, the Internet, and Intellectual 
Property Committee on the Judiciary, 
Martin Frank, Executive Director of 
the American Physiological Society 
(APS), insisted that the issue was not 
access rights but revenue streams [6]. 
The NIH mandate, he argued, “risks 
undermining the revenue stream 
derived principally from subscriptions, 
that enables publishers to add value 
to research articles and to enhance 
readers’ ability to discover and use 
scientists’ work.” Publishers report that 
they are adding as much as US$4,000 
value to a research article, while 
holding that only by virtue of exclusive 
ownership of this public good can they 
see their way to an adequate return on 
investment, in a case of the tail having 
to own the dog in order to wag it [7].
Frank’s stance makes it clear that 
access itself it not the issue. After 
all, APS’s 17 journals already make 
their contents free after 12 months, 
contributing to Highwire Press’ 
2 million freely available articles, 
exceeding the terms of the NIH 
mandate (as APS makes the final 
published version freely available). 
By the same token, the 73 nonprofit 
publishers that belong to the DC 
Principles Coalition, on whose behalf 
Frank was also speaking, are all 
about “free access to science,” as its 
website makes clear (http://www.
dcprinciples.org/). What matters, 
then, as Frank pointed out, was that 
APS “can modify [its current free 
access policy] should 12 months 
prove disadvantageous to the Society’s 
business model” [6]. The point was 
reinforced by the International STM 
Publishers Association, who declared 
in their letter of support for the Fair 
Copyright bill their concerns regarding 
embargoed archiving’s “potential for 
harm to scholarly communication” 
[8]. The association made it clear that 
its members supported “all business 
models – all models that ensure 
continuity and sustainability of the 
journal model that have brought such 
significant insight and information to 
the scientific community.” 
For STM publishers, the NIH 
mandate “puts at risk a system which 
has enabled more research to be 
available to more scientists in more 
countries than at any point in the 
history of science” [8]. But is the 
opposite not true? To insist that the 
current publishing economy must be 
sustained places the system at risk, 
and all the more so amid the current 
economic downturn, which is bound 
to affect research library budgets in 
the coming year. The point has been 
brought home by Heather Joseph, 
executive director of the Scholarly 
Publishing and Academic Resources 
Coalition (SPARC), who testified in 
opposition to the Fair Copyright bill on 
behalf of the leading research libraries, 
which can not sustain subscriptions to 
as many journals as they would like: 
“This situation [in which libraries 
can afford access to only a portion of 
the literature] is exacerbated by the 
continued rapid escalation in price 
of journal subscriptions, which puts 
libraries in the position of having to 
cancel subscriptions” [9]. 
At the root of the problem is the 
current cost of access to knowledge and 
how those costs have come to differ so 
radically from journal to journal that 
one has to wonder about whether the 
progress of science is being served. 
This is the result of the scholarly 
publishing economy that emerged 
during the last half of the twentieth 
century. In that time, the commercial 
scholarly publishers adeptly served the 
greatly expanding scale of government-
sponsored research by providing many 
new journal titles in new areas that 
soon became a critical part of scholarly 
communication. It was a move that 
also enabled commercial publishers to 
run subscription prices up each year 
well over the rate of inflation, with 
some nonprofit societies following 
suit. The result is a publishing system 
in which subscription prices no longer 
correspond to the quantity or quality of 
the work. The price per page charged 
by commercial publishers averaged 
six and seven times that of nonprofit 
society publishers across a number 
of disciplines in one study of journal 
subscriptions pricing [10]. This is 
not only about profits and surpluses, 
but about publishing practices that 
have been built up around these 
different structures over some time. 
If this current stratified economy had 
not been deemed unsustainable by 
those footing the bill, we might leave 
it at that. But some level of public 
accountability seems in order for a new 
digital age that holds such promise for 
universal access to knowledge, with one 
group of publishers exploring open 
access options with article processing 
fees in the area of US$3,000, while a 
new class of open-access journals takes 
advantage of open source software and 
new institutional capacities to publish 
peer-reviewed work without charge to 
either reader or author [11]. 
Which is only to say that the real 
battle for the future of science is not 
about NIH’s provision of delayed access 
to author’s drafts. It is about efforts to 
protect unsustainable revenue streams 
amid the capitalization of a public good 
to a degree that arguably undermines 
what is basic to the progress of science 
and useful arts. If the publishers’ 
exclusive ownership of this body of 
work enables them to charge what 
they will, on their own terms, then 
what is at risk is the delicate-at-best 
balance between public interests in 
such learning and private investments 
in bringing it to the widest possible 
audience.
The NIH Public Access Policy stands 
as an expression of interest in righting 
the imbalance. It is a transition point, a 
step toward establishing a new economy 
of openness for the progress of science. 
No one has made that more clear 
than NIH director Elias A. Zerhouni 
in his testimony against the Fair 
Copyright bill [12]. Zerhouni spoke of 
how the digital revolution in the life 
sciences has led to far greater data and 
knowledge production, largely based 
on openly sharing genetic information 
and related sources through federally 
financed services, such as the National 
Center of Biotechnology Information 
(NCBI). And in terms of the 
contribution made by the NIH Public 
Access Policy, he reports that “400,000 
users are accessing 700,000 articles 
every day” in PubMed Central [12]. 
Zerhouni spoke, as well, of public 
interest in this knowledge, pointing 
to how the majority of patients now 
turn up at the doctor’s office having 
visited medical Web sites. This interest 
in access to knowledge is bound to 
spread to the other professions and 
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could once count on no one giving a 
second thought, least of all researchers, 
to transferring to them the copyright 
for the entire research corpus, article 
by article, should have sufficient vision 
to see that a new civil rights issue is 
emerging over access to, as well as 
control over, such knowledge. 
Now may be the time to step 
back from these time-consuming 
legislative skirmishes over who should 
determine rights of access to this 
knowledge. What makes far more 
sense at this point, as we move into 
a new publishing medium, is for 
journal publishers, scholarly societies, 
and research libraries to come to the 
table, to rethink cost structures, to 
collaborate on publishing platforms 
and systems, and to explore new 
ways of justifying, rationalizing, and 
allocating what is well over a US$7 
billion investment in the circulation of 
knowledge (to use the figure for STM 
English-language publishing alone) 
[13]. What is needed are ways to 
maximize the progress of science and 
the useful arts as a function of their 
openness and public place. 
You may find the prospects of 
such coordinated and cooperative 
approaches to advancing this public 
good hopelessly naive, even in this 
time of renewed hope and economic 
reconstruction. If so, then I can only 
advise constant, if not increased, 
vigilance on behalf of those with an 
interest in the openness of science. It 
will be a long road forward of strategic 
incremental measures, such as the NIH 
Public Access Policy, with carefully 
orchestrated counter-measures, even 
as a number of us within the academic 
community seek ways to extend this 
vision of public access to all that 
we do in the name of research and 
scholarship.  
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